Nice climate but no upward growth - Recensione dipendente - Partner presso Merck

3,0
4 gen 2025
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

small site, lunches every day, easy work

Svantaggi

Limited opportunities for upward growth, with East Coast colleagues preferring to retain the majority of work and showing reluctance to collaborate.

Esplora altre recensioni su Merck

5,0
29 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Benefits and pay are great

Svantaggi

Depends on manager and organization is how your experience and work life balance will be

4,0
30 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Svantaggi

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Vedi recensioni per: Utile|Valutazione|Data|Tutto